Contracts › HDTRA124C0003
HDTRA124C0003: Infectious Disease Diagnostics and Differentiation of Viral Vs. Bacterial Infections for Point of Care Applications (PHASE III)
Awarded to Genecapture, Inc. by Defense Threat Reduction Agency.
$3.5Mobligated
$4.5Mpotential value
31 July 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HDTRA124C0003 |
|---|---|
| Awardee | Genecapture, Inc. |
| Awarding agency | Defense Threat Reduction Agency |
| Awarding office | DEFENSE THREAT REDUCTION AGENCY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AC33 National Defense R&D Services; Defense-Related Activities; Experimental Development |
| Place of performance | AL |
| Offers received | 1 |
| Period of performance | 03 November 2023 to 31 July 2026 |
| Potential end | 31 July 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record